First human tests begin for potential lung and tumor drug
NCT ID NCT05740475
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new drug called 9MW3811 for the first time in humans. The main goal was to check if it is safe and how well it is tolerated in 32 healthy adults aged 18 to 55. Researchers gave a single dose and monitored for side effects, measuring how the drug moves through the body. This early research is a necessary step before testing the drug in people with diseases like pulmonary fibrosis or tumors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PULMONARY FIBROSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Scientia Clinical Research
Randwick, New South Wales, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new biologic boost standard brain cancer therapy?
- Can AI catch lung scarring that doctors might miss?
- Can a new PET tracer spot thyroid cancer recurrence more clearly?
- What makes someone stop a lung fibrosis drug? a study asks patients directly
- New imaging agent could sharpen cancer detection
- New radiation method targets tough tumors